ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare bile duct cancer in early trials
Disease control Recruiting nowThis study tests an experimental drug, HMPL-453, in adults with advanced bile duct cancer that has a specific change in the FGFR2 gene. The drug is taken as a pill for 14 days, then a week off. The main goal is to see if it shrinks tumors. About 235 people will join.
Matched conditions: ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for bile duct cancer: can targeted radiation boost treatment?
Disease control Recruiting nowThis study is for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that has spread. It tests whether adding liver-directed radiation therapy to standard systemic therapy improves safety and outcomes. About 60 adults with at least one liver tumor 3 …
Matched conditions: ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:59 UTC